Wolf, S., Madanchi, M., Turko, P., Hollmén, M., Tugues, S., Atzigen, J. v., . . . Gousopoulos, E. Anti-CTLA4 treatment reduces lymphedema risk potentially through a systemic expansion of the FOXP3+ Treg population. Nature Portfolio.
Chicago Style (17th ed.) CitationWolf, Stefan, et al. Anti-CTLA4 Treatment Reduces Lymphedema Risk Potentially Through a Systemic Expansion of the FOXP3+ Treg Population. Nature Portfolio.
MLA (9th ed.) CitationWolf, Stefan, et al. Anti-CTLA4 Treatment Reduces Lymphedema Risk Potentially Through a Systemic Expansion of the FOXP3+ Treg Population. Nature Portfolio.
Warning: These citations may not always be 100% accurate.